{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:23:15Z","timestamp":1775251395925,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Szeged Open Access Fund","award":["6548"],"award-info":[{"award-number":["6548"]}]},{"name":"University of Szeged Open Access Fund","award":["6548"],"award-info":[{"award-number":["6548"]}]},{"name":"University of Szeged Open Access Fund","award":["6548"],"award-info":[{"award-number":["6548"]}]},{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The long-term safety and efficacy of repeated applications of subliminal transscleral cyclophotocoagulation (SL-TSCPC) with a focus on cumulative energy was evaluated in glaucoma patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective, multicentric study the data of a total of 82 eyes with various causes of glaucoma that were treated with a single or multiple applications of SL-TSCPC were collected. Treatments were performed under general or local anesthesia with an 810\u00a0nm diode laser. Power was 2000 mW; duty cycle, 31.3%; total treatment duration, 80\u2013320\u00a0s; equaling a total energy of 50\u2013200\u00a0J per treatment session. Fifty-five eyes (55 patients) presented for all follow-ups, and these eyes were selected for further statistical analysis. The mean age was 60.0\u2009\u00b1\u200917.1 years, and 22 (40%) of the patients were female. Intraocular pressure (IOP) and dependence on further glaucoma medication were evaluated at 12 months following the initial treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eyes underwent 1 or 2 consecutive SL-TSCPC treatments. Median (min\u2013max) baseline IOP of 34 (13\u201369) decreased to 21.5 (7\u201361), 22 (8\u201368), 20 (9\u201368), and 19.5 (3\u201360) mmHg at the 1, 3, 6, and 12-month postoperative timepoints respectively. The mean (\u00b1\u2009SD) IOP decrease at 12 months was 26\u2009\u00b1\u200927%, 39\u2009\u00b1\u200932%, and 49\u2009\u00b1\u200933% in the low (below 120\u00a0J, <jats:italic>n<\/jats:italic>\u2009=\u200918), medium (120\u2013200\u00a0J, <jats:italic>n<\/jats:italic>\u2009=\u200924), and high (above 200\u00a0J, <jats:italic>n<\/jats:italic>\u2009=\u200913) cumulative energy groups respectively. At the 12-month timepoint, oral carbonic anhydrase use was discontinued in \u00be of the cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It was found that the repeated application of SL-TSCPC safely and efficiently decreases IOP in a Caucasian population with heterogenous causes of glaucoma, eyes with silicone oil responded to a greater extent. Inclusion of cumulative energy scales may contribute to better addressing repeated procedures in a standardized fashion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03505-7","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T08:02:01Z","timestamp":1717401721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of cumulative energy in repeated subliminal transscleral cyclophotocoagulation: a retrospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"\u00c1ron","family":"Szab\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"\u00c1rp\u00e1dffy-Lovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Hagy\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Cseke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"V\u00e1mosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit","family":"T\u00f3th-Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"6","key":"3505_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u2013713; discussion 829\u2013830 https:\/\/doi.org\/10.1001\/archopht.120.6.701.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"3505_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48\u201356. https:\/\/doi.org\/10.1001\/archopht.121.1.48.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"3505_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130(4):429\u201340. https:\/\/doi.org\/10.1016\/s0002-9394(00)00538-9.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"3505_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archophthalmol.2010.131","volume":"128","author":"AP Tanna","year":"2010","unstructured":"Tanna AP, Rademaker AW, Stewart WC, Feldman RM. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs. Arch Ophthalmol. 2010;128(7):825\u201333. https:\/\/doi.org\/10.1001\/archophthalmol.2010.131.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3505_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in Glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus Eye drops for the Treatment of Glaucoma and ocular hypertension. Ophthalmology. 2023;130(2):139\u201351. https:\/\/doi.org\/10.1016\/j.ophtha.2022.09.009.","journal-title":"Ophthalmology"},{"issue":"2","key":"3505_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00061198-199704000-00010","volume":"6","author":"HD Jampel","year":"1997","unstructured":"Jampel HD. Target pressure in glaucoma therapy. J Glaucoma. 1997;6(2):133\u20138.","journal-title":"J Glaucoma"},{"issue":"6","key":"3505_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archopht.1980.01020031041005","volume":"98","author":"FG Berson","year":"1980","unstructured":"Berson FG, Epstein DL, Grant WM, Hutchinson BT, Dobbs PC. Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol. 1980;98(6):1051\u20134. https:\/\/doi.org\/10.1001\/archopht.1980.01020031041005.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"3505_CR8","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/s0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial Glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943\u201353. https:\/\/doi.org\/10.1016\/s0161-6420(01)00873-9.","journal-title":"Ophthalmology"},{"issue":"5","key":"3505_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789\u2013e8032. https:\/\/doi.org\/10.1016\/j.ajo.2011.10.026.","journal-title":"Am J Ophthalmol"},{"key":"3505_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajo.2017.01.003","volume":"176","author":"PG Christakis","year":"2017","unstructured":"Christakis PG, Zhang D, Budenz DL, et al. Five-year pooled data analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Am J Ophthalmol. 2017;176:118\u201326. https:\/\/doi.org\/10.1016\/j.ajo.2017.01.003.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3505_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0002-9394(14)75758-7","volume":"113","author":"HL Hennis","year":"1992","unstructured":"Hennis HL, Stewart WC. Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma. Am J Ophthalmol. 1992;113(1):81\u20135. https:\/\/doi.org\/10.1016\/s0002-9394(14)75758-7.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"3505_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/s0161-6420(96)30508-3","volume":"103","author":"O Kosoko","year":"1996","unstructured":"Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode laser ciliary ablation Study Group. Ophthalmology. 1996;103(8):1294\u2013302. https:\/\/doi.org\/10.1016\/s0161-6420(96)30508-3.","journal-title":"Ophthalmology"},{"issue":"1","key":"3505_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ceo.12360","volume":"43","author":"MCD Aquino","year":"2015","unstructured":"Aquino MCD, Barton K, Tan AMWT, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43(1):40\u20136. https:\/\/doi.org\/10.1111\/ceo.12360.","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"3505_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/healthcare9111563","volume":"9","author":"HL Chang","year":"2021","unstructured":"Chang HL, Chao SC, Lee MT, Lin HY. Micropulse transscleral cyclophotocoagulation as primary surgical treatment for primary open angle glaucoma in Taiwan during the COVID-19 pandemic. Healthc (Basel). 2021;9(11):1563. https:\/\/doi.org\/10.3390\/healthcare9111563.","journal-title":"Healthc (Basel)"},{"issue":"10","key":"3505_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/IJG.0000000000001925","volume":"30","author":"W Tong","year":"2021","unstructured":"Tong W, Shen TYT, Wong HC, Aquino MC, Chew P, Lim D. One-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2021;30(10):911\u201320. https:\/\/doi.org\/10.1097\/IJG.0000000000001925.","journal-title":"J Glaucoma"},{"issue":"3","key":"3505_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ogla.2019.02.002","volume":"2","author":"S Sarrafpour","year":"2019","unstructured":"Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma. 2019;2(3):167\u201371. https:\/\/doi.org\/10.1016\/j.ogla.2019.02.002.","journal-title":"Ophthalmol Glaucoma"},{"issue":"8","key":"3505_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/IJG.0000000000002051","volume":"31","author":"W Zbiba","year":"2022","unstructured":"Zbiba W, Sayadi S, Kharrat M, Daoued M. Efficacy and safety of Micropulse Transscleral Laser Therapy in Silicone Oil-induced Glaucoma. J Glaucoma. 2022;31(8):689\u201393. https:\/\/doi.org\/10.1097\/IJG.0000000000002051.","journal-title":"J Glaucoma"},{"issue":"12","key":"3505_CR18","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/jcm11123447","volume":"11","author":"VA de Vries","year":"2022","unstructured":"de Vries VA, Pals J, Poelman HJ, Rostamzad P, Wolfs RCW, Ramdas WD. Efficacy and safety of Micropulse Transscleral Cyclophotocoagulation. J Clin Med. 2022;11(12):3447. https:\/\/doi.org\/10.3390\/jcm11123447.","journal-title":"J Clin Med."},{"issue":"3","key":"3505_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/1120672120914231","volume":"31","author":"O Tekeli","year":"2021","unstructured":"Tekeli O, K\u00f6se HC. Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Eur J Ophthalmol. 2021;31(3):1113\u201321. https:\/\/doi.org\/10.1177\/1120672120914231.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"3505_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00417-020-04611-0","volume":"258","author":"N Vig","year":"2020","unstructured":"Vig N, Ameen S, Bloom P, et al. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1073\u20139. https:\/\/doi.org\/10.1007\/s00417-020-04611-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"3505_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10103-019-02922-1","volume":"35","author":"L Magacho","year":"2020","unstructured":"Magacho L, Lima FE, \u00c1vila MP. Double-session micropulse transscleral laser (CYCLO G6) for the treatment of glaucoma. Lasers Med Sci. 2020;35(7):1469\u201375. https:\/\/doi.org\/10.1007\/s10103-019-02922-1.","journal-title":"Lasers Med Sci"},{"issue":"8","key":"3505_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","volume":"26","author":"ME Emanuel","year":"2017","unstructured":"Emanuel ME, Grover DS, Fellman RL, et al. Micropulse Cyclophotocoagulation: initial results in refractory Glaucoma. J Glaucoma. 2017;26(8):726\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000000715.","journal-title":"J Glaucoma"},{"issue":"5","key":"3505_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/IJG.0000000000000934","volume":"27","author":"AL Williams","year":"2018","unstructured":"Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma. J Glaucoma. 2018;27(5):445\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000000934.","journal-title":"J Glaucoma"},{"key":"3505_CR24","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.2147\/OPTH.S313875","volume":"15","author":"TM Grippo","year":"2021","unstructured":"Grippo TM, Sanchez FG, Stauffer J, Marcellino G. MicroPulse\u00ae transscleral laser therapy - fluence may explain variability in clinical outcomes: a literature review and analysis. Clin Ophthalmol. 2021;15:2411\u20139. https:\/\/doi.org\/10.2147\/OPTH.S313875.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3505_CR25","first-page":"94","volume":"7","author":"FG Sanchez","year":"2018","unstructured":"Sanchez FG, Peirano-Bonomi JC, Grippo TM. Micropulse transscleral cyclophotocoagulation: a hypothesis for the Ideal parameters. Med Hypothesis Discov Innov Ophthalmol. 2018;7(3):94\u2013100.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"7","key":"3505_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/IJG.0000000000001862","volume":"30","author":"EJY Lim","year":"2021","unstructured":"Lim EJY, Aquino CM, Lun KWX, et al. Efficacy and safety of repeated micropulse transscleral diode cyclophotocoagulation in advanced glaucoma. J Glaucoma. 2021;30(7):566\u201374. https:\/\/doi.org\/10.1097\/IJG.0000000000001862.","journal-title":"J Glaucoma"},{"key":"3505_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/OPTH.S389198","volume":"17","author":"TM Grippo","year":"2023","unstructured":"Grippo TM, T\u00f6teberg-Harms M, Giovingo M, et al. Evidence-based consensus guidelines series for micropulse transscleral laser therapy - surgical technique, post-operative care, expected outcomes and retreatment\/enhancements. Clin Ophthalmol. 2023;17:71\u201383. https:\/\/doi.org\/10.2147\/OPTH.S389198.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"3505_CR28","first-page":"236","volume":"76","author":"JY Chow","year":"2021","unstructured":"Chow JY, Wan Norliza WM, Bastion MC. Outcomes of Subliminal Transscleral Cyclophotocoagulation treatment in glaucoma. Med J Malaysia. 2021;76(2):236\u201340.","journal-title":"Med J Malaysia"},{"issue":"10","key":"3505_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/IJG.0000000000001023","volume":"27","author":"A Yelenskiy","year":"2018","unstructured":"Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following Micropulse Transscleral Cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27(10):920\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001023.","journal-title":"J Glaucoma"},{"issue":"11","key":"3505_CR30","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1007\/s00417-021-05265-2","volume":"259","author":"O Tekeli","year":"2021","unstructured":"Tekeli O, K\u00f6se HC. Comparative efficacy and safety of micropulse transscleral laser cyclophotocoagulation using different duration protocols in eyes with good visual acuity. Graefes Arch Clin Exp Ophthalmol. 2021;259(11):3359\u201369. https:\/\/doi.org\/10.1007\/s00417-021-05265-2.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3505_CR31","doi-asserted-by":"publisher","unstructured":"Kingston EJ, Lusthaus JA. Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma. Int Ophthalmol. 2023;13. https:\/\/doi.org\/10.1007\/s10792-023-02675-5. Published Online March.","DOI":"10.1007\/s10792-023-02675-5"},{"issue":"3","key":"3505_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/vision4030036","volume":"4","author":"M Nicolai","year":"2020","unstructured":"Nicolai M, Lassandro N, Franceschi A, et al. Intraocular pressure rise linked to silicone oil in retinal surgery: a review. Vis (Basel). 2020;4(3):36. https:\/\/doi.org\/10.3390\/vision4030036.","journal-title":"Vis (Basel)"},{"issue":"9","key":"3505_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/IJG.0000000000001552","volume":"29","author":"RMPC de Crom","year":"2020","unstructured":"de Crom RMPC, Slangen CGMM, Kujovic-Aleksov S, Webers CAB, Berendschot TTJM, Beckers HJM. Micropulse Trans-scleral cyclophotocoagulation in patients with Glaucoma: 1- and 2-Year treatment outcomes. J Glaucoma. 2020;29(9):794\u20138. https:\/\/doi.org\/10.1097\/IJG.0000000000001552.","journal-title":"J Glaucoma"},{"issue":"10","key":"3505_CR34","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s10792-021-01896-w","volume":"41","author":"G Laruelle","year":"2021","unstructured":"Laruelle G, Pourjavan S, Janssens X, Marinescu-George C, Boustani G. Real-life experience of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in advanced and uncontrolled cases of several glaucoma types: a multicentric retrospective study. Int Ophthalmol. 2021;41(10):3341\u20138. https:\/\/doi.org\/10.1007\/s10792-021-01896-w.","journal-title":"Int Ophthalmol"},{"issue":"2","key":"3505_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10103-015-1856-9","volume":"31","author":"S Kuchar","year":"2016","unstructured":"Kuchar S, Moster MR, Reamer CB, Waisbourd M. Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci. 2016;31(2):393\u20136. https:\/\/doi.org\/10.1007\/s10103-015-1856-9.","journal-title":"Lasers Med Sci"},{"issue":"3","key":"3505_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/IJG.0000000000001174","volume":"28","author":"K Zaarour","year":"2019","unstructured":"Zaarour K, Abdelmassih Y, Arej N, Cherfan G, Tomey KF, Khoueir Z. Outcomes of Micropulse Transscleral Cyclophotocoagulation in uncontrolled Glaucoma patients. J Glaucoma. 2019;28(3):270\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001174.","journal-title":"J Glaucoma"},{"issue":"6","key":"3505_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/IJG.0000000000001230","volume":"28","author":"N Benhatchi","year":"2019","unstructured":"Benhatchi N, Bensmail D, Lachkar Y. Benefits of SubCyclo Laser Therapy guided by high-frequency Ultrasound Biomicroscopy in patients with refractory Glaucoma. J Glaucoma. 2019;28(6):535\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000001230.","journal-title":"J Glaucoma"},{"issue":"4","key":"3505_CR38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00417-021-05468-7","volume":"260","author":"HSL Chen","year":"2022","unstructured":"Chen HSL, Yeh PH, Yeh CT, et al. Micropulse transscleral cyclophotocoagulation in a Taiwanese population: 2-year clinical outcomes and prognostic factors. Graefes Arch Clin Exp Ophthalmol. 2022;260(4):1265\u201373. https:\/\/doi.org\/10.1007\/s00417-021-05468-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3505_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/IJG.0000000000001409","volume":"29","author":"C Keilani","year":"2020","unstructured":"Keilani C, Benhatchi N, Bensmail D, et al. Comparative effectiveness and tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation with a duty factor of 25% Versus 31.3% for advanced Glaucoma. J Glaucoma. 2020;29(2):97\u2013103. https:\/\/doi.org\/10.1097\/IJG.0000000000001409.","journal-title":"J Glaucoma"},{"issue":"7","key":"3505_CR40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s10103-019-02934-x","volume":"35","author":"MA Preda","year":"2020","unstructured":"Preda MA, Karancsi OL, Munteanu M, Stanca HT. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci. 2020;35(7):1487\u201391. https:\/\/doi.org\/10.1007\/s10103-019-02934-x.","journal-title":"Lasers Med Sci"},{"key":"3505_CR41","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.2147\/OPTH.S226554","volume":"13","author":"A Al Habash","year":"2019","unstructured":"Al Habash A, AlAhmadi AS. Outcome of MicroPulse\u00ae transscleral photocoagulation in different types of glaucoma. Clin Ophthalmol. 2019;13:2353\u201360. https:\/\/doi.org\/10.2147\/OPTH.S226554.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3505_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","volume":"38","author":"AM Tan","year":"2010","unstructured":"Tan AM, Chockalingam M, Aquino MC, Lim ZIL, See JLS, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38(3):266\u201372. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02238.x.","journal-title":"Clin Exp Ophthalmol"},{"issue":"12","key":"3505_CR43","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.oftale.2020.12.005","volume":"96","author":"AM ELGwaily","year":"2021","unstructured":"ELGwaily AM, Khedr SA, Assaf AH, Latif MA, Elsayed HA, Latif AA. MicroPulse\u00ae transscleral laser therapy in the management of glaucoma patients. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(12):640\u20138. https:\/\/doi.org\/10.1016\/j.oftale.2020.12.005.","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"9","key":"3505_CR44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/IJG.0000000000001900","volume":"30","author":"C Chamard","year":"2021","unstructured":"Chamard C, Bachouchi A, Daien V, Villain M. Efficacy, Safety, and Retreatment Benefit of Micropulse Transscleral Cyclophotocoagulation in Glaucoma. J Glaucoma. 2021;30(9):781\u20138. https:\/\/doi.org\/10.1097\/IJG.0000000000001900.","journal-title":"J Glaucoma"},{"issue":"1","key":"3505_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1120672119877586","volume":"31","author":"S Souissi","year":"2021","unstructured":"Souissi S, Baudouin C, Labb\u00e9 A, Hamard P. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol. 2021;31(1):112\u20139. https:\/\/doi.org\/10.1177\/1120672119877586.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3505_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.aopr.2022.10.003","volume":"3","author":"M Issiaka","year":"2023","unstructured":"Issiaka M, Zrikem K, Mchachi A, et al. Micropulse diode laser therapy in refractory glaucoma. Adv Ophthalmol Pract Res. 2023;3(1):23\u20138. https:\/\/doi.org\/10.1016\/j.aopr.2022.10.003.","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"10","key":"3505_CR47","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/IJG.0000000000000757","volume":"26","author":"JH Lee","year":"2017","unstructured":"Lee JH, Shi Y, Amoozgar B, et al. Outcome of Micropulse Laser Transscleral Cyclophotocoagulation on Pediatric Versus adult Glaucoma patients. J Glaucoma. 2017;26(10):936\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000000757.","journal-title":"J Glaucoma"},{"issue":"7","key":"3505_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.oftal.2020.03.002","volume":"95","author":"C Logioco","year":"2020","unstructured":"Logioco C, Perrone LD, Caruso D, Albertazzi R, Valvecchia G, Zanutigh V. Assessment of efficacy and safety of micropulse diode laser treatment in glaucoma: one year follow-up. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(7):327\u201333. https:\/\/doi.org\/10.1016\/j.oftal.2020.03.002.","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"10","key":"3505_CR49","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/IJG.0000000000001339","volume":"28","author":"VNV Varikuti","year":"2019","unstructured":"Varikuti VNV, Shah P, Rai O, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma. 2019;28(10):901\u20135. https:\/\/doi.org\/10.1097\/IJG.0000000000001339.","journal-title":"J Glaucoma"},{"issue":"Spec 2","key":"3505_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0181-5512(06)73962-6","volume":"29","author":"H Bresson Dumont","year":"2006","unstructured":"Bresson Dumont H, Ballereau L, Lehoux A, Santiago PY. Diode laser in malignant Glaucoma treatment. J Fr Ophtalmol. 2006;29(Spec 2):73\u20137. https:\/\/doi.org\/10.1016\/s0181-5512(06)73962-6.","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"3505_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5005\/jp-journals-10078-1289","volume":"14","author":"LG Waldo","year":"2020","unstructured":"Waldo LG, Julio HQ, Jennifer CV, et al. Combined technique for the application of micropulse cyclophotocoagulation in patients with uncontrolled glaucoma: cyclo mix. J Curr Glaucoma Pract. 2020;14(3):93\u20137. https:\/\/doi.org\/10.5005\/jp-journals-10078-1289.","journal-title":"J Curr Glaucoma Pract"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03505-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T08:03:21Z","timestamp":1717401801000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3505"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03505-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the University of Szeged approved the data acquisition with the participation of the ancillary sites (protocol number: SLTSCPCRET-001; file number: 34\/2022SZTE RKEB). The need for informed consent to data acquisition and data processing has been waivered by the above ethics committee. The data reported in this work contains no personally identifiable information. The study was conducted in accordance with the Tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}